Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH.

Fraser DA, Harrison SA, Schuppan D. Expert Opin Investig Drugs. 2022 Dec;31(12):1269-1278. doi: 10.1080/13543784.2022.2159804.